US Drug Pricing Reform: No More Medicare 'Gravy Train,' Azar Tells Pharma

HHS secretary urges serious proposals from biopharma on enhancing price negotiation in Medicare Parts D and B, promising action from the Administration whether the industry cooperates or not.

A toy train pulling a cargo of money This picture could be a reference to 'money delivery', gravy train, cargo, freight. Also, money supply and transferring money or wiring money.

The US biopharma industry needs to come forward with proposals to effectively address the lack of price negotiation for prescription drugs covered by Medicare and won’t get away with talking points about preserving innovation and access any more, HHS Secretary Alex Azar warned at policy gathering sponsored by the American Enterprise Institute and the USC-Brookings Schaeffer Initiative for Health Policy May 16.

Azar focused on two areas of Medicare drug coverage where the Trump Administration believes there is no price negotiation, or...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access